Open access
Open access
Powered by Google Translator Translator

Evidence-based Medicine

Editorial – “No Raw Data, No Science: Another Possible Source of the Reproducibility Crisis”

23 Feb, 2020 | 22:07h | UTC

No raw data, no science: another possible source of the reproducibility crisis – Molecular Brain (free)

Commentary: How a ‘no raw data, no science’ outlook can resolve the reproducibility crisis in science – by Fujita Health University (free)

Related: Can We Science Our Way out of the Reproducibility Crisis? – Absolutely Maybe Blog (free) AND Study: Evaluating the Replicability of Social Science Experiments (link to abstract and commentaries) AND Five ways to fix statistics – Nature (free) AND Make replication studies ‘a normal and essential part of science,’ Dutch science academy says – Science (free) AND Reproducibility of clinical research in critical care: a scoping review (free) AND Reproducibility Trial Publishes Two Conclusions for One Paper (free)

 

Related Commentary on Twitter

 


PLOS and the University of California Announce Open Access Publishing Agreement

21 Feb, 2020 | 10:34h | UTC

PLOS and the University of California announce open access publishing agreement – PLOS Blogs (free)

Related: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject) AND Plan S: Making Full and Immediate Open Access a Reality (free) AND The war to free science – Vox (free)

 


Opinion – “It’s Insane to Keep Using Mortality as a Primary Endpoint in Critical Care Trials”

21 Feb, 2020 | 10:36h | UTC

It’s insane to keep using mortality as a primary endpoint in critical care trials – PulmCrit (free)

Source: Grupo UTIclínica – HCFMUSP

 


Perspective: How Common Mental Shortcuts Can Cause Major Physician Errors

21 Feb, 2020 | 07:30h | UTC

How Common Mental Shortcuts Can Cause Major Physician Errors – The New York Times (10 articles per month are free)

Related Study: Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery – New England Journal of Medicine ($)

 


Alex Nowbar’s journal reviews—20 February 2020

20 Feb, 2020 | 10:11h | UTC

Alex Nowbar’s journal reviews, 20 February 2020 – The BMJ Opinion (free)

Alex Nowbar reviews the latest research from the top medical journals.

 


Investigation: “Heart doctors ‘held back stent death data’”

19 Feb, 2020 | 08:27h | UTC

Heart doctors ‘held back stent death data’ – BBC (free)

Related: BBC Investigation on the Reporting of the EXCEL Trial Raises Concerns Over the Safety of Stents for Left Main Disease in Patients at Low Risk for Surgery (free investigation, video, and commentaries) AND EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input – TCTMD (free) AND Changing Evidence, Changing Practice – European Association of Cardio-Thoracic Surgery (free)

 


Challenges and Opportunities for Cancer Clinical Trials in Low- and Middle-income Countries

19 Feb, 2020 | 08:30h | UTC

Challenges and opportunities for cancer clinical trials in low- and middle-income countries – Nature Cancer (free PDF)

 

Related Commentary on Twitter

 


A Clinician’s Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies

18 Feb, 2020 | 08:07h | UTC

A Clinician’s Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies – Translational Vision Science & Technology (free)

 

Related Commentary on Twitter

 


Alex Nowbar’s weekly journal review—14 February 2020

16 Feb, 2020 | 21:34h | UTC

Alex Nowbar’s weekly journal review, 14 February 2020 – The BMJ Opinion (free)

“Alex Nowbar reviews the latest research from the top medical journals.”

 


Alex Nowbar’s weekly journal review—7 February 2020

11 Feb, 2020 | 02:16h | UTC

Alex Nowbar’s weekly journal review, 7 February 2020 – The BMJ Opinion (free)

Alex Nowbar reviews the latest research from the top medical journals.

 


Perspective – “Worried About That New Medical Study? Read This First”

11 Feb, 2020 | 01:54h | UTC

Worried About That New Medical Study? Read This First – The New York Times (free)

 


De-implementing Wisely: Developing the Evidence Base to Reduce Low-value Care

9 Feb, 2020 | 20:49h | UTC

De-implementing wisely: developing the evidence base to reduce low-value care – BMJ Quality & Safety (free) (via @brhospitalist)

 


Viewpoint: Potential Consequences of Changing Disease Classifications

9 Feb, 2020 | 20:42h | UTC

Potential Consequences of Changing Disease Classifications – JAMA (free for a limited period)

Author Interview: Potential Consequences of Changing Disease Classifications (free audio)

 


An Overview of Precision Oncology Basket and Umbrella Trials for Clinicians

9 Feb, 2020 | 20:19h | UTC

An overview of precision oncology basket and umbrella trials for clinicians – CA: A Cancer Journal for Clinicians (free)

 


Editorial: Nature Will Publish Peer Review Reports as a Trial

9 Feb, 2020 | 20:17h | UTC

Editorial: Nature will publish peer review reports as a trial – Nature (free)

 


Understanding the use of Observational and Randomized Data in Cardiovascular Medicine

5 Feb, 2020 | 08:15h | UTC

Understanding the use of observational and randomized data in cardiovascular medicine – European Heart Journal (free)

 


Open Access 2019: A Year of Momentum on the Subscription Off-Ramp

4 Feb, 2020 | 08:50h | UTC

Open Access 2019: A Year of Momentum on the Subscription Off-Ramp – Absolutely Maybe Blog (free)

Related: The Future of OA: A Large-scale Analysis Projecting Open Access Publication and Readership (free study and commentary) AND WHO Joins Coalition for Free Digital Access to Health Research (free resources)

 


Opinion: Cash from Cannabis Companies Creates Conflicted Researchers

4 Feb, 2020 | 08:49h | UTC

Cash from cannabis companies creates conflicted researchers – STAT (free)

 


Perspective: Preprints Can Fill a Void in Times of Rapidly Changing Science

2 Feb, 2020 | 20:01h | UTC

Preprints can fill a void in times of rapidly changing science – STAT (free)

 


Perspective: The Renewed Debate About Blinding in Clinical Trials

2 Feb, 2020 | 19:50h | UTC

The Renewed Debate About Blinding in Clinical Trials – Absolutely Maybe Blog (free)

Related Research: Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study – The BMJ (free)

 


Andromeda and ‘Appalling Science’: A Response to Hardwicke and Ioannidis

29 Jan, 2020 | 08:07h | UTC

Andromeda and ‘appalling science’: a response to Hardwicke and Ioannidis – Winton Centre for Risk and Evidence Communication (free)

 

Related Commentary on Twitter

 


Perspective: Expert Opinion is Not Always Right

29 Jan, 2020 | 08:04h | UTC

Expert opinion is not always right – Evidently Cochrane (free)

 


A Disclosure Form for Work Submitted to Medical Journals: A Proposal from the International Committee of Medical Journal Editors

28 Jan, 2020 | 08:49h | UTC

A Disclosure Form for Work Submitted to Medical Journals: A Proposal From the International Committee of Medical Journal Editors – JAMA (free)

 


Alex Nowbar’s weekly journal review—24 January 2020

26 Jan, 2020 | 22:52h | UTC

Alex Nowbar’s weekly journal review, 24 January 2020 – The BMJ Opinion (free)

Alex Nowbar reviews the latest research from the top medical journals.

 


Impact of Blinding on Estimated Treatment Effects in Randomized Clinical Trials: Meta-epidemiological Study

24 Jan, 2020 | 08:10h | UTC

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study – The BMJ (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.